Cargando…

Single-domain antibody screening by isPLA-seq

Single-domain antibody (sdAb) holds the promising strategies for diverse research and translational applications. Here, we describe a method for the adaptation of the in situ proximity ligation assay (isPLA) followed by sequencing (isPLA-seq) to facilitate screening of a high-sensitive, high-through...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Yueyuan, Yan, Fei, Zhou, Ruimin, Li, Mingchen, Ma, Jinyi, Liu, Zhe, Ma, Zhenyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Life Science Alliance LLC 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8548206/
https://www.ncbi.nlm.nih.gov/pubmed/34675071
http://dx.doi.org/10.26508/lsa.202101115
Descripción
Sumario:Single-domain antibody (sdAb) holds the promising strategies for diverse research and translational applications. Here, we describe a method for the adaptation of the in situ proximity ligation assay (isPLA) followed by sequencing (isPLA-seq) to facilitate screening of a high-sensitive, high-throughput sdAb library for a given protein at subcellular and single-cell resolution. Based on the sequence of complementarity-determining region 3 (CDR3), the recombinant sdAb can be produced for in vitro and in vivo utilities. This method provides a general means to identify the functional measure of sdAb and its complementary epitopes and its potential applications to investigate cellular processes.